Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2007;335:1109 (1 December), doi:10.1136/bmj.39409.389421.BE
| The first 100% of the full text of this article appears below. |
Although the track record for successful treatment interventions for acute bronchiolitis has so far been unimpressive,1 a recent trial using nebulised hypertonic saline holds promise.2 This study involved 96 infants with a mean age of 4.7 months admitted to hospital for acute bronchiolitis, who were double blindly randomised to receive nebulised 3% saline or 0.9% saline. The infants in the hypertonic saline group had a clinically significant 26% reduction in length of hospital stay (2.6 v 3.5 days). Treatment was well tolerated with no observed adverse side effects. Maybe there is hope!
Paul N Thiessen, clinical professor
Department of Pediatrics, University of British Columbia, BC Children's Hospital, Vancouver, BC, Canada
pthiessen@cw.bc.ca